More issues

How to Get Opdivo (nivolumab) Covered by Blue Cross Blue Shield in New York: Prior Authorization, Appeals, and Step Therapy Guide

Answer Box: Getting Opdivo Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield of New York requires prior authorization for Opdivo (nivolumab), typically approving coverage for FDA-labeled oncology indications when submitted with complete clinical documentation. The fastest path: have your oncologist submit a PA request through
7 min read

Renewing Aldurazyme (Laronidase) Approval with Cigna in Georgia: Timeline, Documentation & Appeals Guide

Quick Answer: Renewing Aldurazyme Coverage with Cigna in Georgia Cigna requires annual renewal for Aldurazyme (laronidase) with evidence of clinical benefit for MPS I patients. Submit renewal documentation 30-60 days before expiration through your specialist, including updated genetic confirmation, urinary GAG levels, and clinical response data. If denied, Georgia offers
5 min read

How to Get Upstaza (Eladocagene Exuparvovec) Covered by Humana in Washington: Prior Authorization Guide and Appeal Process

Answer Box: Getting Upstaza Covered by Humana in Washington Upstaza (eladocagene exuparvovec) requires prior authorization from Humana and must be administered at a certified neurosurgical center. For Washington residents, the fastest path involves: 1) Confirming AADC deficiency diagnosis with genetic testing and CSF biomarkers, 2) Submitting prior authorization through Humana&
6 min read

How to Get Therakos CELLEX Photopheresis Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cigna Coverage for Therakos CELLEX in New York Cigna requires prior authorization for Therakos CELLEX photopheresis (CPT 36522) as a medical benefit for FDA-approved indications including cutaneous T-cell lymphoma (CTCL) and steroid-refractory graft-versus-host disease (GVHD). Coverage mandates documented progressive disease after failed standard therapies and specialist oversight.
7 min read